Innovative Medicines Initiative: Putting Europe At The Forefront Of Biopharmaceutical Innovation

The Innovative Medicines Initiative (IMI), the public-private partnership between the European Commission and the European pharmaceutical industry, represented by EFPIA, today made its first major announcement of the success of the collaboration. IMI also announced the topics of research of its second call for proposals.